Skip to main content

NEUROCRINE BIOSCIENCES INC

For the period ended Apr 9, 2025. Filed Apr 9, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Apr 9, 2025 · Filed Apr 9, 2025

NBIX$164.63+3.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Proxy Summary

This summary highlights information that is described in more detail elsewhere in this proxy statement. This summary does not contain all the information you should consider before you vote, and you should read the entire proxy statement carefully before voting.

General Information

Annual Meeting of Stockholders
Meeting Date:May 21, 2025
Time:10:30 a.m. Local Time
Place:6027 Edgewood Bend Court, San Diego, California 92130
Record Date:March 24, 2025

How to Vote

Your vote is very important. Whether or not you plan to attend the Annual Meeting, we hope you will vote as soon as possible. You may vote in the following ways:

Telephone: Call 1-800-690-6903 from any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the meeting date. Have your proxy card in hand when you call and then follow the instructions. Easy-to-follow voice prompts allow you to submit your proxy and confirm your instructions have been properly recorded.

Internet: Visit www.proxyvote.com to transmit your voting instructions and for electronic delivery of information via the Internet up until 11:59 P.M. Eastern Time the day before the meeting date. As with telephone voting, you can confirm that your instructions have been properly recorded.

Mail: Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

Matters to be Voted On

MatterBoard of DirectorsRecommendationPage Reference forMore Information
Proposal One: Elect Class II DirectorsFOR all nominees21
Proposal Two: Advisory vote on executive compensationFOR23
Proposal Three: Approve 2025 Equity Incentive PlanFOR24
Proposal Four: Approve an amendment and restatement of the Company's 2018 Employee Stock Purchase PlanFOR36
Proposal Five: Ratify Ernst & Young LLP as independent registered public accounting firmFOR42
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.